Optional Sub-study to Intraoperative Imaging With ICG Registry
Status: | Recruiting |
---|---|
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 9/14/2018 |
Start Date: | December 2015 |
Contact: | Sunil Singhal, MD, Ph.D |
Email: | PennCancerTrials@emergingmed.com |
Phone: | 855-216-0098 |
The primary goal of this optional sub-study is to record what tissues fluoresce in the
operating room, and then to identify if these lesions are cancer when the histopathology is
performed.
operating room, and then to identify if these lesions are cancer when the histopathology is
performed.
Inclusion Criteria:
- Adult patients >= 18 years of age
- Patients presenting with any solid tumor and/or diseased tissue even benign nodules
presumed to be resectable and are at risk for recurrence.
- Good operative candidate as determined by the treating physician and/or
multidisciplinary team
- Subject capable of giving informed consent and participating in the process of
consent.
Exclusion Criteria:
- Pregnant women as determined by urinary or serum beta hCG within 72 hours of surgery
- Vulnerable patient populations
We found this trial at
1
site
3400 Civic Center Blvd
Philadelphia, Pennsylvania 19104
Philadelphia, Pennsylvania 19104
(215) 662-6065

Principal Investigator: Sunil Singhal, MD, PhD
Phone: 855-216-0098
Abramson Cancer Center of the University of Pennsylvania The Abramson Cancer Center of the University...
Click here to add this to my saved trials
